Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-02
1998-06-16
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 24, 514 42, 536 41, 536 172, A61K 3170, C07H 1500
Patent
active
057670935
ABSTRACT:
Antibody-mediated xenograft rejection is attenuated by parenterally administering a xenoantibody-inhibiting amount of an identified carbohydrate xenoantigen to the recipient shortly before graft revascularization and thereafter.
REFERENCES:
patent: 4137401 (1979-01-01), Lemieux et al.
patent: 4238473 (1980-12-01), Lemieux et al.
patent: 4362720 (1982-12-01), Lemieux et al.
patent: 5079353 (1992-01-01), Ratcliffe et al.
R. Nowak, Science, 266, 1148-1151, 1994.
W. J. Herbert et al. Dictionary of Immunology--3rd Ed., Blackwell Scientific Publications, Oxford, UK, 1985, pp. 14 and 105.
I. M. Toitt, Essential Immunology--5th Ed., Blackwell Scientific Publications, Oxford, UK, 1984, p. 222.
F. H. Bach et al. in D.K.C. Cooper et al (Eds), Xenotransplantation, Springer-Verlag, 1991, pp. 81-99.
P.J.C. Van Breda Vriesman in M.A. Hardy (Ed), Xenograft 25, Elsevier Science Publishers BV, Amsterdam, 1984, pp. 267-271.
The Merck Manual, 16th Ed., Berkow, et al. Eds. pp. 346-354.
Abbas, et al., "Tumor-Associated Oligosaccharides II: Synthesis of SialyI-X Antigenic Determinant", Proc. Japanese-German Symp. Berlin, pp. 2O-21 (1988).
Agishi, et al., "Double Filtration Plasmapheresis", Trans. Am. Soc. Artif. Internal Organs, vol. XXVI, pp. 406-409 (1980).
Alexandre, et al., "Plasmapheresis and splenectomy in experimental renal xenotrasplantation", Xenograft, 25, pp. 259-266 (1989).
Alexandre, et al., "Present Experiences in A Series of 26 ABO-Incompatible Living Donor Renal Allografts", Transpl. Proc., vol. XIX, No. 6, pp. 4538-4542 (Dec. 1987).
Amvam-Zollo, et al., "Streptococcus pneumoniae Type XIV Polysaccharide: Synthesis of A Repeating Branched Tetrasaccharide With Dioxa-Type Spacer-Arms", Carbohydr. Res., vol. 150, pp. 199-212 (1986).
Bannett, et al., "Experiences With Known ABO-Mismatched Renal Transplants", Transpl. Proc., vol. XIX, No. 6, pp. 4543-4546 (Dec. 1987).
Bensinger, et al., "In Vitro and In Vivo Removal of Anti-A Erythrocyte Antibody by Adsorption to a Synthetic Immunoadsorbent", Transfusion, vol. 21, No. 3, pp. 335-342 (May-Jun. 1981)
Bensinger, et al., "ABO-Incompatible Marrow Transplants" Transpl., vol. 33, No. 4, pp. 427-429 (1982).
Bensinger, et al., "Whole Blood Immunoadsorption of Anti-A or Anti-B Antibodies", Vox Sang, 48, pp. 357-361 (1985).
Bier, et al., "Selective Plasmapheresis in Dogs For Delay of Heterograft Response", Trans. Amer. Soc. Artif. Internal Organs, vol. XVI, pp. 325-333 (1970).
Caves, et al., "Hyperacute Rejection of Orthotopic Cardiac Allografts in Dogs Following Solubilized Antigen Pretreatment.sup.1 ", Transpl., vol. 16, No. 3, pp. 252-256 (1973).
Chernyak, et al., "A New Type of Carbohydrate-Containing Synthetic Antigen: Synthesis of Carbohydrate-Containing Polyacrylamide Copolymers Having The Specificity of 0:3 And 0:4 Factors Of Salmonella", Carbohydr. Res., vol. 128, pp. 269-282 (1984).
Chien, et al., "Isolation and characterization of a heptaglycosylceramide from bovine erythrocyte membranes", J. of Lipid Res., vol. 20, pp. 669-673 (1979).
Cooper, et al., "Effects of Cyclosporine and Antibody Adsorption on Pig Cardiac Xenograft Survival in the Baboon", J. Heart Transpl., 7, pp. 238-246 (1988).
Cox, et al., "A New Synthesis of 4-0-.alpha.-D-GALACTOPYRANOSYL-D-GALACTOPYRANOSE", Carbohy. Res., vol. 62, pp. 245-252 (1978).
Dahmen, et al., "2-Bromoethyl glycosides*: applications in the synthesis of spacer-arm glycosides", Carbohydr. Res., vol. 118, 292-301 (1983).
Dahmen, et al., "Synthesis of Spacer-Arm, Lipid, and Ethyl Glycosides of The Trisaccharide Portion Blood-Group P.sup.K Antigen: Preparation of Neoglycoproteins", Carbohy. Res., vol. 127, pp. 15-25 (1984).
Dubois, et al., "Colorimetric Method For Determination of Sugars and Related Substances", Analytical Chem., vol. 28, No. 3, pp. 350-356 (1956).
Egge, et al., "Immunochemistry of I/i-active Oligo-and Polyglycosylceramides from Rabbit Erythrocyte Membranes", J. Biol. Chem., vol. 260, pp. 4927-4935 (1985).
Ekborg, et al., "Synthesis of Three Disaccharides For The Preparation of Immunogens Bearing Immunodeterminants Known To Occur on Glycoproteins", Carbohydr. Res., vol. 110, pp. 55-67 (1982).
Eto, et al., "Chemistry of Lipid of the Posthemolytic Residue or Stroma of Erythrocytes", J. Biochem., vol. 64, No. 2, pp. 205-213 (1968).
Fernandez-Santana, et al., "Glycosides of Monoallyl Diethylene Glycol. A New Type of Spacer Group For Synthetic Oligosaccharides", J. Carbohydr. Chem., vol. 8, pp. 531-537 (1989).
Fischel, et al., "Prolonged Survival of a Discordant Cardiac Xenograft in a Rhesus Monkey", Transpl. Proc., vol. 23, No. 1, pp. 589-590 (Feb. 1991).
Fugedi, et al., "Thioglycosides as Glycosylating Agents in Oligosaccharide Synthesis", Glycoconj. J., vol. 4, pp. 97-108 (1987).
Galili, et al., "Evolutionary relationship between the natural anti-Gal antibody and the Gal.alpha.1.fwdarw.3Gal epitope in primates", Proc. Natl. Acad. Sci. USA, vol. 84, pp. 1369-1373 (Mar. 1987).
Galili, et al., "Human Natural Anti-.alpha.-Galactosyl IgG", J. Exp. Med., vol. 162, pp. 573-582 (Aug. 1985).
Galili, et al., "Man, Apes and Old World Monkeys Differ from other Mammals in the Expression of .alpha.-Galactosyl Epitopes on Nucleated Cells", J. of Biol. Chem., vol. 263, No. 33, pp. 17755-17762 (1988).
Garegg, et al., "A synthesis of 8-methoxycarbonyloct-1-yl O-.alpha.-D-Galactopyranosyl-(1.fwdarw.3)-O-.beta.-D-Galactopyranosyl-(1.f wdarw.4)-2-Acetamido-2-Deoxy-.beta.-D-Glucopyranoside", Carbohy. Res., vol. 136 pp. 207-213 (1985).
Garegg, et al., "Synthesis of 6-and 6'-deoxy derivatives of methyl 4-O-.alpha.-D-galactopyranosyl-.beta.-D-galactopyranoside for studies of inhibition of pyelonephritogenic fimbriated E. coli adhesion to urinary epithelium-cell surface" Carbohy. Res. vol. 137, pp. 270-275 (1985).
Ghilchik, et al., "Platelet Trapping by Sheep Kidney and Heart Xenografts in the Dog", J. of Surgical Res., vol. 17, pp. 434-440 (1974).
Giles, et al., "Mechanism and Modification of Rejection of Heterografts Between Divergent Species", Transpl. Proc., vol. 11, No. 4, pp. 522-537 (Dec. 1970).
Holgersson, et al., "Carbohydrate Antigen Specificity of Pig Lymphocytotoxic IGM Antibodies Produced by Two EBV Transformed Human B Cell lines", Glycoconjugate J. vol. 8, No. 3, p. 172 (1991).
Holgersson, et al., "Structural Characterization of Non-Acid Glycosphingolipids in Kidneys of Single Blood Group O and A Pigs", J. Biochem., vol. 108, pp. 766-777 (1990).
Jacquinet, et al., "Synthesis of Blood-group Substances Part 11. Synthesis of the Trisaccharide O-.alpha.-D-galactopyranosyl-(1.fwdarw.3)-O-.beta.-D-Galactopyranosyl-(1.f I!, pp. 326-330 (1981).
Kameyama, et al., "Total synthesis of sialyl Lewis X*", Carbohydr. Res., vol. 209, C.sub.1 -C.sub.4 (1991).
Killion, "Carbohydrate interference of complement-dependent cell lysis", Experientia, vol. 43, pp. 327-329 (1987).
Koike, et al., "Total synthesis of Globotriaosyl-E and Z-Ceramides and Isoglobotriaosyl-E-ceramide", Carbohy. Res. vol. 163, pp. 189-208 (1987).
Lalezari, et al., "Carbohydrate-Specific Antibodies in Normal Human Sera", Vox Sang vol. 47, pp. 133-145 (1984).
Laus, et al., "Carbohydrate-Specific Human Heterophile Antibodies in Normal Human Sera that React with Xenogeneic Cells", Int. Archs. Allergy Appl. Immun., vol. 85, pp. 201-207 (1988).
Lee, et al., "Synthesis of 3-(2-Aminoethylthio)Propyl Glycosides", Carbohydr. Res., vol. 37, 193-201 (1974).
Linn, et al., "Renal Xenograft Prolongation by Suppression of Natural Antibody", J. of Surgical Res. vol. 8, No. 5, pp. 2ll-213 (1968).
MacDonald, et al., "ABO-Incompatible Living Related Donor Kidney Transplantation: Report of Two Cases", Transpl. Proc., vol. 21, No. 2, pp. 3362-3363 (Apr. 1989).
U.S. Patent application No. 07/270,950, Mazid et al., filed Nov. 9, 1988.
McAlack, et al., "Delayed Hyperacute Rejection in an ABO-Incompatible Renal Transplant", Transpl. Proc., vol. XIX, No. 6, pp. 4558-4560 (Dec. 1987).
Merkel, et al., "Modification of Xenograft Response by Selective Plasmapheresis", Transpl. Proc., vol. 111, No .1, pp. 534-537 (Mar. 1971).
Moberg, et al., "Prolongation of Renal Xenografts by the S
Cooper David K. C.
Good A. Heather
Malcolm Andrew J.
Alberta Research Council
Fonda Kathleen K.
Integris Baptist Medical Center, Inc.
LandOfFree
Methods for attenuating antibody-mediated xenograft rejection in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for attenuating antibody-mediated xenograft rejection in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for attenuating antibody-mediated xenograft rejection in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726154